A new study reports a novel combination of two targeted drugs dramatically slowed the growth of brain cancer tumors and significantly extended survival in mouse models.
The RIP1 protein can either protect or destroy brain tumors, a new study suggests.
Researchers suggest neural stem cells could be resistant to radiation. The stem cells could be roused from a hibernation-like state in order to reproduce and generate new cells which have the ability to migrate, replace injured cells and restore lost function.
New research shows the transmembrane protein NG2 controls orientation of cell migration towards a wound.
Researchers discover a way to adjust the malignancy of glioma brain cancer cells in a newly developed 3D hydrogel. The new material mimics the conditions in the brain.
An experimental nanotechnology drug crosses the blood-brain barrier and targets brain tumor cells, a new study suggests. The drug also blocks the growth of tumor blood vessels.
A new study discovers molecular pathways that could lead to new targeted therapies which may potentially treat Glioblastoma, the most common and lethal form of brain cancer in adults.
Researchers discover the genetic landscape of the most common form of brain tumor can be explained by abnormalities in five genes. The finding could help to develop personalized medical therapies and treatment options.
In a study published in Neuro-Oncology, researchers at Mayo Clinic identify an important association between the naturally occurring enzyme Kallikrein 6, also known as KLK6, and glioblastoma multiforme tumors.
Scientists have long believed that glioblastoma multiforme, the most aggressive type of primary brain tumor, begins in glial cells that make up supportive tissue in the brain or in neural stem cells. Researchers found that the tumors can originate from other types of differentiated cells in the nervous system, including cortical neurons.